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Abstract
Bombesin receptor subtype 3 (BRS-3), the orphan bombesin receptor, may play a role in the regulation of stress responses
in lung and airway epithelia. Bombesin receptor activated protein (BRAP )is a novel protein we found in our previous study
which interacts with BRS-3. This study was designed to observe the subcellular location and wound repair function of BRAP
in human bronchial epithelial cells (HBECs). BRAP ORF was amplified by RT-PCR and ligated to pEGFP-C1 vector, and then
the recombinant plasmid pEGFP-C1-BRAP was transfected into Hela cells. The location of BRAP protein was observed by
laser confocal microscope, and the expression of it was analyzed by Western-blot. At the same time,we built the
recombinant plasmid pcDNA3.1(+)-BRAP, transfected it into HBECs and observed its impact on cell cycle and wound repair
of HBECs. The results showed that BRAP locates in membrane and cytoplasm and increases significantly in transfected cells.
Flow cytometry results demonstrated that the recombinant plasmid increases S phase plus G2 phase of cell cycle by 25%.
Microscopic video analysis system showed that the repair index of wounded HBECs increases by 20% through stable
expression of BRAP. The present study demonstrated that BRAP locates in the membrane and cytoplasm, suggesting that
this protein is a cytoplasm protein, which promotes cell cycle and wound repair of HBECs.
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Introduction
There is accumulating evidence that BLPs and their receptors
play an important role in pathological conditions of the lung,
including chronic inflammatory lung disease, lung cancer,
bronchopulmonary dysplasia and acute lung injury. Bombesin
receptor subtype-3 (BRS-3, BB3) is a GPCR that has been
resistant to deorphanization. First discovered in 1992 through
homology screening approaches, BRS-3 was assigned to the
bombesin receptor family for its high sequence similarity to two
mammalian bombesin receptors: 47% to Neuromedin B receptor
(NMB-R, BB1) and 51% to Gastrin-releasing peptide receptor
(GRP-R, BB2) [1,2].
Unlike GRP and NMB receptors, which have a widespread
distribution in the central nervous system and peripheral tissues,
the distribution of BRS-3 in the majority of normal tissues is
extremely low, whereas its level in the developing lung and certain
lung carcinomas is high [3–5]. There is very little known about the
biological function of BRS-3 activation. This is in great part
because the natural ligand of BRS-3 has not yet been identified.
However, results from our previous experiments demonstrated
that the expression of BRS-3 mRNA was significantly up-
regulated in an ozone-stressed airway hyperresponsiveness animal
model and resulted in wound repair and Th1-type immune
response [6–7]. Using bacterial two-hybrid technology, we
observed that BRS-3 can interact with a variety of proteins which
are related with cell growth, differentiation, anti-apoptotic,
cytoskeleton assembly, tyrosine kinase activation and so on. We
also found that BRS-3 interacts with a new protein named as
bombesin receptor activated protein( BRAP) in present study.
To further study the structure and function of BRAP, its
subcellular localization and effects on cell proliferation and wound
repair were studied, which will provide theoretical basis for the
interaction of BRAP and BRS-3 in stress response of bronchial
epithelial cells.
Materials and Methods
Cell lines and culture
An immortalized human bronchial epithelial cell line(16-
HBE14o-) and Hela cell line were maintained in a mixture
medium of DMEM:F12(1:1) supplemented with 100 mg/ml
penicillin, 100 mg/ml streptomycin and 10% newborn bovine
serum. Cells were incubated at 37uC in a humidified incubator
with 5% CO2.
Cloning of BRAP from HBECs
Total RNA was isolated from HBECs using TRIzol reagent
(Invitrogen, USA) according to the manufacturer’s protocol.
Superscript RNase
H- Reverse Transcriptase (Invitrogen) and an
oligo (dT) primer were used to synthesize the first strand cDNA.
PCR reaction (59-GCCC aga tct GAT TTT ATA TTG GAA
GAC-39 forward and 59-GCCA ctg cag CAG TTC TGA GAA
AGC GC-39 reverse) was performed as follows: 94uC for 5 min,
then 30 cycles of 94uC for 30 s, 47uC for 30 s,72uC for 45 s,
and then a final extension at 72uC for 10 min. Amplification of
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CAGGGTACATGGTGGTGCC-39reverse) was used as a control
for sample loading and normalization. The primers used were
listed in Table 1. RT-PCR products were ligated into a pGEM-T-
easy vector. Subsequently, the plasmid was transformed into E.coli
strain DH5. Bacteria were cultured in 800 mL of LB medium for
45 min at 37uC and 225r/min. After incubation, bacteria were
plated onto agar plates containing ampicillin(100 mg/L), X-
gal(20 mg/cm
2)and IPTG(12 mg/cm
2) and incubated overnight
at 37uC.White colonies were selected and identified by sequencing.
Construction of BRAP expression vectors
pEGFP-C1 and pcDNA3.1 (+) vectors were purchased from
clontech (USA). The transcript BRAP was digested by BglII/PstI
and inserted into pEGFP-C1 and pcDNA3.1(+) plasmids,
respectively. Both constructs were confirmed by sequencing and
digest.
Cell transfection and fluorescence imaging
The expression vectors were transfected into Hela and HBECs
using LipofectamineTM 2000 reagent (Invitrogen) according to
the manufacturer’s protocol. Empty pEGFP-C1 and pcDNA3.1
(+) plasmids were transfected respectively as control. After pEGFP-
C1-BRAP plasmid was transfected into Hela 48 hours later, GFP
expression was recorded using confocal laser scanning microscopy.
pcDNA3.1(+)-BRAP plasmid was transfected into HBECs.
Positive cell clones were obtained by antibiotic selection for 2
weeks with G418 (Gibco,Grand Island,NY) at a concentration of
600 ug/ml. The stable transfectants used in this study were stained
with propidium iodide and analyzed by flow cytometry and
monolayer wound repair assay.
Protein extraction and Western blotting analysis
The level of protein expression was evaluated by Western
blotting analysis using specific antibodies. Hela cells transfected
with pcDNA3.1 (+) and pcDNA3.1 (+)-BRAP were collected from
the plates. The samples were lysed in ice-cold cell lyses buffer (1%
Triton X-100, 150 mM NaCl, 10 mM Tris-HCl (pH 7.4), 2 mM
sodium orthovanadate, 10 mg/ml leupeptin, 50 mM NaF, 5 mM
EDTA, 1 mM EGTA, and 1 mM PMSF) by stirring for 1 h at
4uC. The lysates were obtained after a centrifugation at 13,0006g
for 15 min. An equal volume of Laemmle sample buffer was
added to each cell lysate. Samples were boiled for 10 min, and
then equal amounts of protein were separated by 7.5% SDS-
PAGE before being transferred to nitrocellulose membrane. The
membrane were blocked with 3% BSA in PBS for 2 h and then
incubated with antibodies and appropriate horseradish peroxi-
dase-conjugated secondary antibody. Detection was made using
the enhanced chemiluminescene system.
Measurement of cell cycle by flow cytometry
After being cultured in 6-well plates, cells were harvested at a
density of 1610
6 Cells/mL, fixed in cold 70% ethanol and stored
at 220uC overnight. The fixed cells were washed twice with
phosphate-buffered Saline, stained in a propidium iodide solution
(50 ug/ml) for 1 hour, and treated with a ribonuclease A solution
(20 ug/ml) for 30 minutes. Flow cytometry was then using to
examine cell cycle. Experiments were repeated 3 times.
Monolayer wound repair assay
This assay was used to demonstrate the effect of BRAP
overexpression on migration and wound repair of epithelial cells.
We have previously published details of this method. Briefly [6],
HBECs transfected with pcDNA3.1 (+)-BRAP were grown until
confluent in 12-well plates with DMEM: F12 (1:1), and a small
wound was made in the confluent monolayer with a rubber stylet.
The edge of wound was recognized and the remaining wound area
was measured serially per 4 hours in 24 h by video microscopy
(Olympus Company, Japan). A linear regression equation of the
remaining wound area to time was obtained. Repair index (RI),
equal to the absolute value of slope, was used to judge the repair
speed of HBECs.
Statistical analyses
The data were analyzed using unpaired Student’s t-test. Values
were expressed by mean6SE. P,0.05 was considered as
statistically significant.
Results
Cloning and sequence analysis of BRAP transcript from
HBECs
The nucleotide sequence of BRAP has been deposited in Gene
Bank with accession number NM-152734. The original ORF of
BRAP is composed of 1065 nt and putatively 354 amino acid
residues(Figure S1A). n present study, the ORF of BRAP was
generated by RT-PCR amplification from mRNA of HBECs
(Figure S1B), subcloned into pGEM-T-easy vector, and identified
by sequencing.
Identification of amplified plasmids
After being digested by endonucleases BgI II and Pst I, the
plasmid pEGFP-C1-BRAP (Figure S2A) showed 2 bands of about
5 Kb and 1 Kb, and restriction enzyme analysis of the plasmid
pcDNA3.1(+)-BRAP with BamHI and XhoI yielded approximate-
ly 5 Kb empty pcDNA3.1(+) and 1 Kb BRAP (Figure S2B).
Subcellular localization of BRAP
A GFP fusion expression construct, pEGFP-C1-BRAP, was
transfected into cultured Hela cells in order to visualize the
subcellular localization of BRAP. Fluorescence was measured at
48 h post-transfection using confocal microscopy. As shown in
Figure S3, GFP-BRAP clearly locates in the membrane and
cytoplasm.
Expression of BRAP protein in transfected HBECs
To investigate the expression of BRAP protein, western blotting
analysis of cell lysates was performed utilizing the specific rabbit
anti-BRAP polyclonal antibody and revealed that pcDNA3.1(+)
Table 1. Primers used in this study.
Primers
name primer sequence(59-39) purpose
FP1 GCCC aga tct GAT TTT ATA TTG GAA GAC RT-PCR
RP1 GCCA ctg cag CAG TTC TGA GAA AGC GC RT-PCR
FP2 GCCC aga tct GAT TTT ATA TTG GAA GAC pEGFP-C1-BRAP
RP2 GCCA ctg cag CAG TTC TGA GAA AGC GC pEGFP-C1-BRAP
FP3 GCCC gga tcc GAT TTT ATA TTG GAA GAC pcDNA3.1(+)-BRAP
RP3 GCCA ctc gag CAG TTC TGA GAA AGC GC pcDNA3.1(+)-BRAP
FP—actin AGCGCGAAATCGTGCGTG beta-actin
RP—actin CAGGGTACATGGTGGTGCC beta-actin
doi:10.1371/journal.pone.0023072.t001
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BRAP compared with mock plasmid-transfected cells and
untransfected cells (Figure S4) .
Cell cycle measurement by flow cytometry
The ratio of S-phase in cells transfected with pcDNA3.1 (+)-
BRAP was significantly higher than in cells transfected with
pcDNA3.1 (+) and untransfected cells (Figure S5A). The ratio of S-
phase was shown by columns (
*p,0.05, Figure S5 B)
Effects of BRAP overexpression on wound repair
PCDNA3.1 (+) - BRAP and PCDNA3.1 (+) transfected HBECs
were cultured in 24 well plates to 90% confluence, and then
changed into serum-free culture medium for 24 h. The cell layer
was caused a minor mechanical wound by scratching and
monitored for 24 h by the use of BI-2000 image immunohisto-
chemical analysis system, outlining the edge of wound area (Figure
S6 A). Compared with pcDNA3.1(+) transfected cells, the repair of
HBECs was accelerated significantly after BRAP overexpression.
(Figure S6 B).
Discussion
BRS-3 is one of G protein-coupled receptors which are the
largest family of cell surface molecules involving in signal
transduction and represent about 3% of the human genome. By
use of bacterial two-hybrid technology, we found a new protein
interaction with BRS-3. Bioinformatics analysis showed that full-
length cDNA of the new protein is 6751 bp and locates at 6p21.2
(access number: NM_152734), with ORF length 1065 bp
encoding a 354 amino acid protein. Northern Blot analysis
showed that BRAP is expressed in HBECs, embryonic tissues and
tumor tissues.
Subcellular localization of proteins is an important aspect of
protein function study. Protein synthesis in the ribosome, and then
the boot to specific organelles, involved in a variety of cell life
activities, such as cell cycle regulation, cell signal transduction and
transcriptional regulation. In case of deviation, it will be of
significant impact on the entire cell function [8,9]. To study the
subcellular localization of BRAP, we constructed a plasmid
PEGFP-BRAP by fusion to green fluorescent protein (GFP).
Using laser scanning confocal microscope, we observed BRAP
locates in membrane and cytoplasm. Western blot results showed
that the protein is highly expressed in transfected cells.
The signal transduction of BRS-3 in different cells or under
different stimuli can lead to different cell responses depending on
whether the intracellular signaling molecules assemblies with
different upstream and downstream molecules, i.e. assemblies of
different signaling molecules determine the different responses.
Stress responses of HBECs, include cell proliferation and repair,
expression of adhesion molecules and adhesion with inflammatory
cells to transmit stress signals, intake and presenting antigen to
activate lymphocytes and so on [10–13]. In the mechanism of
stress signaling transmission in HBECs to produce airway
hyperresponsiveness, BRAP may be involved in assembling with
specific signal molecules.
BRAP was cloned into pcDNA3.1 (+) multiple cloning sites and
the effects on stable over-expression of BRAP in HBECs on cell
cycle were observed. The cell cycle consists of four distinct phases:
G1 phase, S phase (synthesis), G2 phase (collectively known as
interphase) and M phase (mitosis). Activation of each phase is
dependent on the proper progression and completion of the
previous one. Cells that have temporarily or reversibly stopped
dividing are said to have entered a state of quiescence called G0
phase. Our results showed that, BRAP promotes transformation
from G1 to S phase, accelerates cell into DNA synthesis phase,
thereby promoting DNA synthesis and cell proliferation.
To further determine the effects of BPAP activation in AHR,
we tried to observe the effects of BPAP on wound repair of
BECs. Bronchial epithelial cells are the first line of defense
against external stimuli, which are not only the mechanical
barrier, but play an important role in the homeostasis of local
microenvironment of the lungs. Injury or dysfunction of
bronchial epithelial cells leading to imbalance of local micro-
environments may be the initiating link of asthma and other
airway diseases. It is reported that the wound repair mainly
depends on migration and proliferation. In the prophase of
wound repair, the precursor cells around the wound initiate the
migration and dissemination. Then the proliferation takes place
around16–20 h after the damage [14–15]. The results showed
that BRAP promotes the repair and proliferation of BECs.
However, whether the increase of wound repair is associated
with increasing cell adhesion or losing contact inhibition
between cells needs further research.
Supporting Information
Figure S1 A: Depicted are 1065 base pairs of DNA sequence of
the human. The predicted protein sequence is shown below the
nucleotide sequence. B: BRAP mRNA expression in HBECs was
assayed by RT-PCR. 1: represents b- actin; 2: represents BRAP
PCR products; 3: represents DNA mark 2000 plus.
(TIF)
Figure S2 Recombinant plasmids were assayed by restriction
enzyme analysis. A 1: Digestion the plasmid pEGFP-C1-BRAP by
BgI II/Pst I; 2: DNA marker; 3: pEGFP-C1-BRAP. B 1: Digestion
the plasmid pcDNA3.1-BRAP by Bam H1/Xho I; 2: DNA
marker; 3: pcDNA3.1-BRAP.
(TIF)
Figure S3 Subcellular localization of BRAP protein in Hela
cells. A: Normal Hela Cells; B: pEGFP-C1 transfected Hela cells;
C pEGFP-C1-BRAP transfected Hela cells.
(TIF)
Figure S4 Expression of the BRAP-encoded protein in HBECs
after transfection. A 1: cells transfected with pcDNA3.1(+)-BRAP
plasmid; 2: cells transfected with mock plasmid(pcDNA3.1(+))
transfected; 3: parent cells. B Quantification of Western blots
normalized to the level of B-actin.
(TIF)
Figure S5 The influence of BRAP overexpression on cell cycle
of HBECs. A:1, Parent cells; 2, Cells transfected with pcDNA3.1
(+); 3, Cells transfected with pcDNA3.1 (+)-BRAP; B: S-phase cells
expressed were shown by columns. (
*p,0.05, n=3).
(TIF)
Figure S6 The influence of BRAP on wound repair of HBECs.
RI was used to evaluate the speed of wound repair. A: typical
video micrographs of HBECs monolayer wound closure; B:
Closure of monolayer wounds in HBECs after transfection with
pcDNA3.1 (+)-BRAP. (
*p,0.05 vs control and PCDNA3.1(+)).
(TIF)
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